Gait Disorder, Sensorimotor, Gait Disorders, Neurologic
Conditions
Brief summary
Adaptive gait assessements will be evaluated as a potential new marker for tracking locomotor recovery throughout rehabilitation of spinal cord injury subjects. To this end, controls, subacute and chronic patients will be assessed at two timepoints with 3 month standard rehabilitation inbetween. The specific assessments will require the participant to acitvely modulate their gait pattern to fullfill specific task constraints. Their performance will be assessed via 3D kinematics, kinetics and EMG and these measures will be used to describe the adaptive capacity that the patient retains. Sensitivity and specificity of these markers will be determined. With more sensitive descriptors of gait function and quality, locomotor rehabilitation for SCI can be better designed and smaller effects can be accurately measured.
Interventions
BEHAVIORALStandard locomotor therapy
Typical clinical therapy.
Sponsors
Foundation Wings For Life
University of Zurich
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Informed Consent as documented by signature (Appendix Informed Consent Form) * Healthy controls * Patients with an incomplete spinal cord injury in a chronic (at least 12 months post-injury) or subacute (3-6 months post-injury) stage of recovery * Age: 18 years and older * Able to stand without physical assistance and handrails for more than 120s * preserved segmental and cutaneo-muscular reflexes in the lower limbs * Bodyweight over 20 kg and under 120 kg * Mini-Mental state examination score 26 (test only performed if cognitive deficits are suspected)
Exclusion criteria
* Current orthopedic problems * Neurological impairment other than SCI * Premorbid major depression or psychosis * Metal implants in the cervical skull * History of significant autonomic dysreflexia with treatment * Dermatological issues (e.g. decubitus) at the harness attachment site (back, abdomen, upper legs) * Malignant diseases * Heart insufficiency NYHA III-IV * Potential pregnancy * Unlikely to complete the intervention or return for follow-up * Participation in another training study * Contraindications for training using the GRAIL (according the manual)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in kinematics | Baseline and through study completion, an average of 4 months | Recording of movement tasks |
Countries
Switzerland
Outcome results
None listed